Henry Schein, Inc. operates in a robust sector, providing essential healthcare products and services worldwide. Despite recent market variability, the company's strategic focus on healthcare distribution and technology-enabled services positions it well for future growth. The stock shows a stable performance with room for improvement in certain financial metrics.
Henry Schein's current fundamental rating stands at B+, indicating a stable financial health with balanced metrics across evaluation categories.
| Category | Score | Visualization |
|---|---|---|
| Discounted Cash Flow | 4 | |
| Return on Equity | 3 | |
| Return on Assets | 5 | |
| Debt to Equity | 1 | |
| Price to Earnings | 2 | |
| Price to Book | 3 |
The historical data shows consistent performance metrics over the recent period, reflecting stable operational efficiency.
| Date | Overall | DCF | ROE | ROA | Debt/Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-10-17 | 3 | 4 | 3 | 5 | 1 | 2 | 3 |
| Prior | 0 | 4 | 3 | 5 | 1 | 2 | 3 |
Analysts offer a mixed outlook with a median price target slightly above the current trading price, indicating modest potential for appreciation.
| High | Low | Median | Consensus |
|---|---|---|---|
| $86 | $75 | $83 | $81.33 |
Current analyst consensus is a 'Hold', with a notable number of analysts issuing buy recommendations, reflecting a balanced risk-reward outlook.
| Recommendation | Count | Visualization |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 13 | |
| Hold | 14 | |
| Sell | 3 | |
| Strong Sell | 0 |
Henry Schein, Inc. maintains a strong foothold in the healthcare distribution market, with its diversified product lines aiding in stable revenue streams. Financial indicators suggest fundamental robustness, albeit with some leverage concerns. Analyst ratings propose a "Hold", signaling room for strategic growth or caution. The stock's potential for moderate appreciation is aligned with the current market scenario, yet external market factors could influence future performance significantly.